Boothbay Fund Management’s Bluejay Diagnostics BJDX Stock Holding History
Bought
Maintained
Sold
Other funds holding BJDX
Boothbay Fund Management's BJDX Position: Q3 2026 in Review
Boothbay Fund Management sold out of Bluejay Diagnostics (BJDX) in Q3 2026, closing a stake of 6,783 shares — an estimated $32.6K sold.
Boothbay Fund Management first reported a position in BJDX in Q2 2026 and held it in 1 quarter. The position peaked at $32.6K in Q2 2026. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.
- Boothbay Fund Management reported no remaining Bluejay Diagnostics position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 6,783 Bluejay Diagnostics shares in Q3 2026, an estimated $32.6K.
- Boothbay Fund Management first reported a position in Bluejay Diagnostics in Q2 2026 and held it in 1 quarter.
- Boothbay Fund Management's Bluejay Diagnostics position peaked at $32.6K in Q2 2026.
- 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.